COVID-19: Variant has strong cell binding: ‘Fugaku’ analyzes
Kyoto University: Platelets are made from iPS cells and administered: Venture ‘Megakaryon’
NIH to Launch Massive ACTIV-6 Phase 3 Clinical Study
Kyoto University: Granted iPS cell license to Avery: Cardiomyocyte manufacturing method